Nabumetone Tablet
Product Images NDC 63629-8508

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 63629-8508). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

This is a table showing the plasma concentrations of Nabumetone Active Metabolite (BMNA) at steady state following once-daily dosing of Nabumetone. The table compares the concentrations at 1000mg (31 patients) and 2000mg (12 patients) doses of Nabumetone. The x-axis represents time in hours.*

FDA Label Image

Label (Lbl636298508)

This is a description of Nabumetone Tablet, USP, a medication that contains 500 mg of nabumetone USP per tablet. It is important to keep this medication out of reach of children and store it at 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). The medication is dispensed in a tight container with a child-resistant closure. The NDC code for this medication is 63629-8508-1 and it is distributed by BRP Pharmaceuticals. It is available in a container of 100 tablets and is only available by prescription.*

FDA Label Image

Structure1 (Structure1)

FDA Label Image

Structure2 (Structure2)

6-methoxy-2-naphthylacetic acid (SMNA) is a chemical compound consisting of an acetic acid molecule linked to a naphthalene ring with a methoxy group and has the molecular formula COOH-CHgO.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.